HIV/AIDS Therapy
Novel technique enables single-cell latency analysis
Published in AIDS Weekly, September 2nd, 2002
"The ability of human immunodeficiency virus type 1 (HIV-1) to establish latent infections in cells has received renewed attention owing to the failure of highly active antiretroviral therapy to eradicate HIV-1 in vivo," according to Olaf Kutsch and colleagues at the University of Alabama at Birmingham and the Howard Hughes Medical Institute in Birmingham, Alabama. "Despite much study, the molecular bases of HIV-1 latency and reactivation are incompletely understood."
Kutsch and coauthors constructed a HIV...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2002-09-02)
More Articles from AIDS Weekly
- Adverse Drug Effects
Drug eruption study yields surprising results - HIV/AIDS Vertical Transmission
Short-course nevirapine doesn't improve standard preventive therapy - Drug Resistance
UCSD study shows increased transmission of drug-resistant HIV infection - HIV-associated Nephropathy
Viral Nef protein triggers podocyte growth and proliferation - AIDS Therapy
T-20 administration has little impact on daily activities of patients after 8 weeks of treatment - Epidemiology
Vietnam reports 9000 new people detected as HIV-positive - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
